» Articles » PMID: 9430688

Identification of Regulatory Phosphorylation Sites in Mitogen-activated Protein Kinase (MAPK)-activated Protein Kinase-1a/p90rsk That Are Inducible by MAPK

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 1998 Jan 27
PMID 9430688
Citations 146
Authors
Affiliations
Soon will be listed here.
Abstract

Mitogen-activated protein kinase-activated protein kinase-1 (MAPKAP-K1; also known as p90rsk) contains two protein kinase domains in a single polypeptide. The N-terminal kinase domain is necessary for the phosphorylation of peptide substrates, whereas the C-terminal kinase domain is required for full activation of the N-terminal domain. Here we identify six sites in MAPKAP-K1a that become phosphorylated in transfected COS-1 cells. The inactive form of MAPKAP-K1a in unstimulated cells is partially phosphorylated at Ser222 and Ser733. Stimulation with phorbol 12-myristate 13-acetate induces the phosphorylation of Thr360, Ser364, Thr574, and Ser381 and increases the phosphorylation of Ser222 and Ser733. Our data indicate that mitogen-activated protein kinase activates the C-terminal kinase domain by phosphorylating Thr574 and contributes to the activation of the N-terminal kinase domain by phosphorylating Ser364. The activated C-terminal domain phosphorylates Ser381, which, together with phosphorylation of Ser364, activates the N-terminal kinase domain. The phosphorylation of Ser222 and Ser733, which can be catalyzed by the N-terminal domain, does not activate MAPKAP-K1a per se, but Ser222 phosphorylation appears to be required for activation. Ser222, Ser364, and Ser381 are situated in analogous positions to phosphorylation sites in protein kinase B, protein kinase C, and p70S6K, suggesting a common mechanism of activation for these growth factor-stimulated protein kinases.

Citing Articles

Insulin signaling and pharmacology in humans and in corals.

Murthy M, Jasbi P, Lowe W, Kumar L, Olaosebikan M, Roger L PeerJ. 2024; 12:e16804.

PMID: 38313028 PMC: 10838073. DOI: 10.7717/peerj.16804.


The cell cycle, autophagy, and cell wall integrity pathway jointly governed by MoSwe1 in Magnaporthe oryzae.

Li L, Zhu X, Bao J, Wang J, Liu X, Lin F Cell Commun Signal. 2024; 22(1):19.

PMID: 38195499 PMC: 10775494. DOI: 10.1186/s12964-023-01389-6.


Novel Bifunctional Affibody Molecules with Specific Binding to Both EBV LMP1 and LMP2 for Targeted Therapy of Nasopharyngeal Carcinoma.

Kamara S, Guo Y, Wen H, Liu Y, Liu L, Zheng M Int J Mol Sci. 2023; 24(12).

PMID: 37373272 PMC: 10299379. DOI: 10.3390/ijms241210126.


Inhibition of p90RSK Ameliorates PDGF-BB-Mediated Phenotypic Change of Vascular Smooth Muscle Cell and Subsequent Hyperplasia of Neointima.

Hwang A, Lee H, Kim S, Park S, Woo C Int J Mol Sci. 2023; 24(9).

PMID: 37175802 PMC: 10179136. DOI: 10.3390/ijms24098094.


p90RSK Regulates p53 Pathway by MDM2 Phosphorylation in Thyroid Tumors.

Maietta I, Peschio F, Buonocore P, Viscusi E, Laudati S, Iannaci G Cancers (Basel). 2023; 15(1).

PMID: 36612117 PMC: 9817759. DOI: 10.3390/cancers15010121.